Phase 1 Viral reactivation Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Donor-Derived Viral Specific T-cells (VSTs)

Viral reactivationallogeneic stem cell transplantViral Infection

Children's Hospital Medical Center, Cincinnati750 enrolled3 locationsNCT02048332

Recruiting

Phase 1

Virus-specific T cell therapy for transplant recipients

recurrent or drug-resistant viral infectionViral reactivationBK polyomavirus+1 more

QIMR Berghofer Medical Research Institute25 enrolled4 locationsACTRN12621000323820